Navigation Links
Access Pharmaceuticals to Attend the 36th Annual Oncology Nursing Society Congress
Date:4/27/2011

DALLAS and NEW YORK, April 27, 2011 /PRNewswire/ -- ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, diabetes and RNAi, will attend this year's Oncology Nursing Society (ONS) Congress at the Boston Convention and Exhibition Center in Boston, MA.  The company's MuGard booth (#652) will be displayed in the Exhibition Hall of the convention center from Thursday, April 28th to Saturday, April 30th.

"We are excited to have a strong presence at the 36th Annual ONS Congress meeting," said Frank Jacobucci, VP of Sales and Marketing, Access Pharmaceuticals, Inc.  He continued, "ONS is well regarded as a premier event for educating oncology nurses on novel therapies and products used in cancer treatment regimens.  Oncology nurses remain on the front lines when treating patients for side effects of chemotherapy and radiation, especially when preventing and managing oral mucositis. Feedback on MuGard from oncology nurses has been overwhelmingly positive and we look forward to the meeting's ideal platform for broadening our already strong reach within the oncology nurse community."

About ONS:The Oncology Nursing Society (ONS) is a professional organization of over 35,000 registered nurses and other healthcare providers dedicated to excellence in patient care, education, research, and administration in oncology nursing. ONS members are a diverse group of professionals who represent a variety of professional roles, practice settings, and subspecialty practice areas. Registered nurses, including staff nurses, advanced practice nurses, case managers, educators, researchers, and consultants, and other healthcare professionals, benefit from membership. The Society offers useful information and opport
'/>"/>

SOURCE Access Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
2. Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
3. Hypertension: Journal of the American Heart Association Rapid Access Reports: Hispanics Hypertension Better Controlled With Equal Access to Care
4. Anesiva Announces Pivotal Phase 3 Trial of Zingo(TM) Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults
5. Access Pharmaceuticals to Present Data on ProLindac(TM) at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
6. Access Pharmaceuticals Announces Two Poster Presentations Reporting Significant Preclinical Data on ProLindac(TM) at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
7. Demand for Spanish-Language Cancer Web Materials Quadruples; Internet Resources and Access Remain Scarce
8. New Analysis from 14 Countries Identifies Drug Access Priorities to Achieve 2010 AIDS Treatment Target
9. Access Pharmaceuticals Demonstrates Ability to Significantly Reduce Glucose Levels in Pre-clinical Testing of Cobalamin(TM) Oral Insulin
10. Childrens Hospital Cancer Study Finds Adolescents and Young Adults Dont Get Same Access to Cutting-Edge Treatment as Younger Patients
11. Insmed Provides Update on IPLEX(TM) Expanded Access Program in Italy for the Treatment of Amyotrophic Lateral Sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... , Aug. 28, 2015 Perrigo Company ... on the Mylan N.V. ("Mylan") (NASDAQ: MYL ) ... Perrigo. "Our views of Mylan,s offer to ... be, based on our Board,s careful reflection of the ... on the limited choices that Mylan has allowed its ...
(Date:8/28/2015)... -- The report "Eubiotics Market by Type (Probiotics, Prebiotics, Organic ... & by Region ( North America , ... Rest of the World) - Global Trends and Forecast to ... valued at USD 4.62 Billion in 2014 and is projected ... of 7.4% from 2015 to 2020. Browse ...
(Date:8/27/2015)... 27, 2015  A recent study by Feucht ... compared the Arthrosurface HemiCAP® Wave implant, which is ... "onlay" design implant for isolated patellofemoral disease. While ... and pain scores, none of the patients in ... However, 53% of the patients in the "onlay" ...
Breaking Medicine Technology:Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 2Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 3Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 4Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 5Eubiotics Market Worth 7.05 Billion USD by 2020 2Eubiotics Market Worth 7.05 Billion USD by 2020 3Eubiotics Market Worth 7.05 Billion USD by 2020 4Eubiotics Market Worth 7.05 Billion USD by 2020 5Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 2Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 3
... for Fatal Disease, CAMBRIDGE, Mass., Oct. 2 ... it has completed the first phase,of a comprehensive gene-expression ... model of amyotrophic lateral sclerosis -- ALS, or Lou,Gehrig,s ... for completion by February of 2008. This study is ...
... YORK, Oct. 1 Keryx Biopharmaceuticals,Inc. (Nasdaq: KERX ... President, will present an overview of the Company,s cancer,pipeline ... Stock,Conference in New York City. Dr. Henderson,s presentation will ... Dr. Henderson,s presentation will be webcast live and ...
Cached Medicine Technology:ALS TDI Completes Gene Expression Profile of Lou Gehrig's Disease in Mice 2ALS TDI Completes Gene Expression Profile of Lou Gehrig's Disease in Mice 3Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference 2
(Date:8/30/2015)... ... August 30, 2015 , ... Lizzie’s Lice Pickers , a company ... The company is currently offering lice head checks for just $10, which is a ... a 10% discount on their lice treatment products. “With kids returning to school, it ...
(Date:8/30/2015)... ... 2015 , ... Certified Nutrition Businessman Reid Eckert agrees to extend his business ... a global sales and communications firm that offers U.S. brands a proven path to ... with Mr. Reid Eckert, as his interpretation of the nutritional needs of the human ...
(Date:8/29/2015)... ... , ... Rio Salado College President Chris Bustamante announced on Aug. ... Strategic Initiatives and Information Services. O’Shea, who has served Rio Salado for the last ... impact through innovative technologies and strategies. , “I am very proud to be able ...
(Date:8/29/2015)... ... 2015 , ... "I have been a licensed physical therapist ... in manual therapy, and my invention will provide headache sufferers a solution to ... dysfunction throughout the body." , They developed THE RELIEVER to alleviates headaches, as ...
(Date:8/29/2015)... , ... August 29, 2015 , ... Brands like ... with zero standard shipping costs. , “Before, a threshold of $49.00 was required to ... brands and items qualify for free standard shipping for customers regardless of the item’s ...
Breaking Medicine News(10 mins):Health News:Lizzie’s Lice Pickers Announces Back to School Head Check Special and Discounted Lice Treatment Products 2Health News:Nutrition Guru Continues Relationship With Renowned Health and Wellness Company 2Health News:Rio Salado College Appoints New Vice President of Strategic Initiatives and Information Services 2Health News:Inventors and InventHelp Clients Develops Tension Reliever (LGI-1951) 2Health News:TheBeautyPlace.com Discounts Shipping on Select Brands 2
... people know that you can use,your heart rate to ... be used,in other ways, too. "Your heart rate can ... system," says Stan Reents, PharmD, a certified personal,trainer, fitness ... increases as exercise intensity increases. By,plugging their age into ...
... A Difference, SEATTLE, Oct. 16 Seattle-based retailer Affirmagy ... make a difference,for women who are newly diagnosed with breast ... so giving is as easy as,clicking a button. "We ... the life of a,woman who has been diagnosed with breast ...
... (NYSE:,VTR) ("Ventas" or the "Company") announced today that it ... close of trading on Thursday,November 8, 2007. A conference ... November 9, 2007 at 10:00 a.m. Eastern Time (9:00 ... CCBN and can be accessed at the,Company,s website at ...
... Missing For #1 Cancer Killer, WASHINGTON, Oct. 15 ... Ambrose said that figures released,earlier today showing an overall ... she warned while the incidence and,mortality rates in lung ... Public health policy officials credited screening as one of ...
... WYE ),confirmed today that it will appeal the ... in the Second Judicial District Court in Reno,Nevada, beginning ... presided over the trial. "This flawed verdict is ... V. Stein, Wyeth,s Senior Vice President and General Counsel.,"The ...
... Sole Source Agreement Supports JHSMH IT Strategy, ... PER ) today said that Jewish Hospital ... based in Louisville, KY, has,selected the company to ... The financial terms of the 10-year agreement were ...
Cached Medicine News:Health News:Exercise And Health: Use Your Heart Rate As a Guide 2Health News:If You Build It, They Will Give 2Health News:Overall Drop in Cancer Death Rate Does Not Apply to Women With Lung Cancer 2Health News:Wyeth to Appeal Nevada Hormone Therapy Trial Verdict 2Health News:Wyeth to Appeal Nevada Hormone Therapy Trial Verdict 3Health News:Jewish Hospital & St. Mary's Healthcare Select Perot Systems for Technology Services 2Health News:Jewish Hospital & St. Mary's Healthcare Select Perot Systems for Technology Services 3
The pocket-size Invacare Digit finger pulse oximeter is a convenient and economical solution to fast, reliable SpO2, pulse rate and pulse strength measurements. Its compact size is ideal for home use...
The Onyx® 9500 worlds first self-contained digital fingertip pulse oximeter incorporates the electronics and the sensor into one unit....
Ergonomically designed, the Invacare Printing Pulse Oximeter provides fast, reliable spot-check information and documentation of SpO2 and pulse rate. It is ideal for all patients from neonate to adul...
... Pulse Oximeter monitors SpO2, pulse ... is designed to provide fast, ... The device rejects spontaneous motion ... operator of excess artifacts and ...
Medicine Products: